澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

NEUREN PHARMACEUTICALS LTD

20.210

+0.0100.05%

成交量：31.14万

成交额：624.73万

市值：25.59亿

市盈率：129.62

高：20.310

开：20.220

低：19.430

收：20.200

52周最高：23.588

52周最低：10.920

股本：1.27亿

流通股本：1.08亿

量比：1.21

换手率：0.29%

股息：0.15

股息率：0.74%

每股收益(TTM):0.156

每股收益(LYR):0.233

净资产收益率：6.17%

总资产收益率：2.58%

市净率：7.68

市盈率(LYR):86.85

数据加载中...

总览公司新闻资讯公告

概念

医药生物股+0.66%

资金流向

资金流入：

资金流出：

新闻资讯

强大的合作伙伴销售业绩推动Neuren Pharmaceuticals跃居澳大利亚行业基准榜首

若获欧盟市场授权并上市，NEUREN PHARMACEUTICALS LTD 首笔商业销售后将获3500万美元

Neuren Pharmaceuticals 正重新评估资本管理方案，包括延续股票回购与启动税后股息

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/NEU.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":20.21,"timestamp":1791781920000,"preClose":20.2,"halted":0,"volume":311392,"delay":0,"changeRate":0.0004950495049505725,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":108394581,"shares":126639526,"eps":0.155917,"marketStatus":"未开盘","change":0.01,"latestTime":"10-12 16:12:00 AEDT","open":20.22,"high":20.31,"low":19.43,"amount":6247291,"amplitude":0.043564,"askPrice":20.3,"askSize":2500,"bidPrice":20.08,"bidSize":1590,"shortable":3,"etf":0,"ttmEps":0.155917,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":20.2,"dividendRate":0.007422,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":1.208067,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NEU.AU","preClose":20.2,"auctionPrice":20.21,"auctionVolume":54332,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781816092}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":108394581,"roa":"2.58%","roe":"6.17%","lyrEps":0.2327,"volumeRatio":1.208067,"shares":126639526,"dividePrice":0.15,"high":20.31,"amplitude":0.043564,"preClose":20.2,"low":19.43,"week52Low":10.92,"pbRate":"7.68","psRate":"36.81","week52High":23.588,"institutionHeld":0,"latestPrice":20.21,"committee":-0.222494,"eps":0.155917,"divideRate":0.007422,"volume":311392,"delay":0,"ttmEps":0.155917,"open":20.22,"prevYearClose":18.475,"prevWeekClose":20.2,"prevMonthClose":20.35,"prevQuarterClose":20.35,"fiveDayClose":20.43,"twentyDayClose":20.52,"sixtyDayClose":16.827},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"NEU.AU","amount":0.15,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-16","defaultRemindTime":1789430400000,"name":"NEUREN PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-07","payableDate":"2026-09-16","currency":"AUD","dateTimestamp":1789394400000,"payDate":"2026-10-07"},{"date":"2026-08-26","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2026-09-15","recordDate":"2026-09-16","paymentDate":"2026-10-07","value":0.15,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEU.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657946745","title":"强大的合作伙伴销售业绩推动Neuren Pharmaceuticals跃居澳大利亚行业基准榜首","url":"https://stock-news.laohu8.com/highlight/detail?id=2657946745","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657946745?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 11:34","pubTimestamp":1785900870,"startTime":"0","endTime":"0","summary":"BUZZ-强大的合作伙伴销售业绩推动Neuren Pharmaceuticals跃居澳大利亚行业基准榜首8月5日-**Neuren PharmaceuticalsNEU.AX股价一度上涨18.2%，至22.00澳元，创下自2025年10月31日以来的最高水平**** 该公司表示， (link) Acadia PharmaceuticalsACAD.O——NEU曾向其授予DAYBUE（特罗菲奈肽）口","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4T4420AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","LU2065170008.USD","LU2065171402.SGD","ACAD","BK7508","LU2065169927.USD","NEU.AU","BK4139","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183210271","title":"若获欧盟市场授权并上市，NEUREN PHARMACEUTICALS LTD 首笔商业销售后将获3500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183210271","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183210271?lang=zh_cn&edition=fundamental","pubTime":"2026-06-29 05:45","pubTimestamp":1782683146,"startTime":"0","endTime":"0","summary":"若其产品在欧盟获得市场授权并成功上市，NEUREN PHARMACEUTICALS LTD 将在完成首笔商业销售后，有权获得3500万美元的款项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","NEU.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118300837","title":"Neuren Pharmaceuticals 正重新评估资本管理方案，包括延续股票回购与启动税后股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1118300837","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118300837?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 11:24","pubTimestamp":1779852294,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals 目前正在对其资本管理策略进行全面重估。公司考虑的方案包括继续执行现有的股票回购计划，以及启动派发税后股息。这一评估旨在优化资本结构，提升股东回报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","NEU.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NEU.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"医药生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.006583}]}}